Meeting
2020 ASCO Virtual Scientific Program
Improving cancer pain control: Potential impact of CYP2D6 pharmacogenomic (PGx) testing in oncology (Onc) patients.
Authors
Natalie Reizine
University of Chicago Medical Center, Chicago, IL
Natalie Reizine , Keith Danahey , Emily Schierer , Tien Truong , Mark J. Ratain , Peter H. O'Donnell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 38: 2020 (suppl; abstr 12089)
DOI
10.1200/JCO.2020.38.15_suppl.12089
Abstract #
12089
Poster Bd #
377
Abstract Disclosures
Similar Posters
Poster
2019 Supportive Care in Oncology Symposium
Pharmacogenetic (PGx) guided cancer pain management in an oncology palliative medicine (PM) clinic.
First Author: Jai Narendra Patel
Poster
2017 Palliative and Supportive Care in Oncology Symposium
Opioid epidemic or pain crisis? Exploring prescription opioid medication utilization for patients with cancer in rural Southwest Virginia.
First Author: Virginia T. LeBaron
First Author: Talya Salz
Poster
2023 ASCO Annual Meeting
Opioid use, gabapentinoid use, and pain-related emergency department visits for patients living with advanced cancer.
First Author: Vikram Jairam